{{Rsnum
|rsid=579543
|Gene=IL1RN
|Chromosome=2
|position=113132054
|Orientation=minus
|GMAF=0.1896
|Gene_s=IL1RN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 47.8 | 5.3
| HCB | 90.5 | 9.5 | 0.0
| JPT | 92.0 | 8.0 | 0.0
| YRI | 85.7 | 13.6 | 0.7
| ASW | 84.2 | 14.0 | 1.8
| CHB | 90.5 | 9.5 | 0.0
| CHD | 91.7 | 7.3 | 0.9
| GIH | 44.0 | 42.0 | 14.0
| LWK | 83.6 | 16.4 | 0.0
| MEX | 27.6 | 62.1 | 10.3
| MKK | 92.3 | 7.7 | 0.0
| TSI | 50.0 | 46.1 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23602982
|Title=IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort
}}

{{PMID Auto
|PMID=17443229
|Title=Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels.
}}

{{PMID Auto
|PMID=19104506
|Title=Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer.
}}

{{on chip | Affy GenomeWide 6}}